Document is current
Any future updates will be listed below
-
Authors
Benoit, Patrick
Brazer, Noah
de Lorenzi-Tognon, Mikael https://orcid.org/0000-0002-2969-542X
Kelly, Emily https://orcid.org/0000-0003-2986-0285
Servellita, Venice
Oseguera, Miriam https://orcid.org/0009-0004-9621-2848
Nguyen, Jenny
Tang, Jack
Omura, Charles
Streithorst, Jessica
Hillberg, Melissa
Ingebrigtsen, Danielle
Zorn, Kelsey https://orcid.org/0000-0003-1227-2137
Wilson, Michael R. https://orcid.org/0000-0002-8705-5084
Blicharz, Tim https://orcid.org/0000-0002-0371-7547
Wong, Amy P.
O’Donovan, Brian
Murray, Brad
Miller, Steve
Chiu, Charles Y. https://orcid.org/0000-0003-2915-2094
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | Centers for Disease Control and Prevention (75D30121C12641, 75D30122C15360)
U.S. Department of Health & Human Services | Biomedical Advanced Research and Development Authority
Chan-Zuckerberg Biohub
- License Information
-
More Information
Article History
Received: 21 April 2024
Accepted: 28 August 2024
First Online: 12 November 2024
Competing interests
: A.P.W., B.O., T.B., B.M. and S.M. are employed by and own equity in Delve Bio. C.Y.C. is a co-founder of Delve Bio and on the scientific advisory board for Delve Bio, Flightpath Biosciences, Biomeme, Mammoth Biosciences, BiomeSense and Poppy Health. He is also an inventor on US patent 11380421, ‘Pathogen detection using next-generation sequencing’, under which algorithms for taxonomic classification, filtering and pathogen detection are used by SURPI+ software. C.Y.C. receives research support from Delve Bio and Abbott Laboratories, Inc. M.R.W. is a co-founder and on the scientific advisory board for Delve Bio. The other authors declare no competing interests.
